A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer
Clinical trial NCT00500292 · COMPLETED
Trial details
- NCT number
- NCT00500292
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-03-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.